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Abstract
Background: The role of host immunity has been recognized as not only playing a fundamental role in the
interaction between the host and pathogen but also in influencing host infectiousness and the ability to shed
pathogens. Despite the interest in this area of study, and the development of theoretical work on the immuno-
epidemiology of infections, little is known about the immunological processes that influence pathogen shedding
patterns.
Results: We used the respiratory bacterium Bordetella bronchiseptica and its common natural host, the rabbit, to
examine the intensity and duration of oro-nasal bacteria shedding in relation to changes in the level of serum
antibodies, blood cells, cytokine expression and number of bacteria colonies in the respiratory tract. Findings show
that infected rabbits shed B. bronchiseptica by contact up to 4.5 months post infection. Shedding was positively
affected by number of bacteria in the nasal cavity (CFU/g) but negatively influenced by serum IgG, which also
contributed to the initial reduction of bacteria in the nasal cavity. Three main patterns of shedding were identified:
i- bacteria were shed intermittently (46% of individuals), ii- bacteria shedding fell with the progression of the
infection (31%) and iii- individuals never shed bacteria despite being infected (23%). Differences in the initial
number of bacteria shed between the first two groups were associated with differences in the level of serum
antibodies and white blood cells. These results suggest that the immunological conditions at the early stage of the
infection may play a role in modulating the long term dynamics of B. bronchiseptica shedding.
Conclusions: We propose that IgG influences the threshold of bacteria in the oro-nasal cavity which then affects
the intensity and duration of individual shedding. In addition, we suggest that a threshold level of infection is
required for shedding, below this value individuals never shed bacteria despite being infected. The mechanisms
regulating these interactions are still obscure and more studies are needed to understand the persistence of
bacteria in the upper respiratory tract and the processes controlling the intensity and duration of shedding.
Background
An appreciation of the immunological mechanisms that
affect the interaction between the host and its pathogens
is crucial for an understanding of the epidemiology of
infection [1-4]. By linking within-host immunological
processes to the between-host dynamics of infection it is
possible to explain, and ultimately prevent, the conditions
that allow for the invasion and survival of a pathogen
within a host and the consequences for transmission.
Fundamental to this is the knowledge of how the
immune response affects pathogen replication and
clearance as well as the intensity and duration of shed-
ding and, thus, transmission.
Chronic bacteria infections can pose a challenge to the
study of host infectiousness and associated immune
response in that bacteria can either persist in the host,
despite an acute inflammatory phase and active immu-
nity, or colonize and persist without causing any appar-
ent clinical or symptomatic effects [5-7]. Bacteria can
activate their pathogenicity at a later time by triggering
serious disease and high infectiousness or can increase
their transmission rate in response to changes in host
susceptibility [8-12]. These findings suggest that
immune-compromised and chronically infected hosts
can act either as life-long bacteria shedders or shed bac-
teria for a restricted period, usually coinciding with the
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chronic infections, we need to identify not only the key
immunological processes that affect long term pathogen
persistence but also how pathogen replication, intensity
and duration of bacteria shedding is associated with the
immune response.
Here, we investigated the relationship between
immune response and shedding rate in a chronic bac-
teria infection using the Bordetella bronchiseptica-rabbit
system. Our recent work on the epidemiology of
B. bronchiseptica in a free living population of rabbits
(Oryctolagus cuniculus) showed that this is a common
and persistent infection: annual prevalence ranged
between 88% and 97% and by 2 months of age, 65% of
the individuals had already seroconverted [13]. A model
for bacteria infection was suggested where the annual
recruitment of new infected individuals was associated
with the onset of the host breeding season and the avail-
ability of new naïve offspring. Breeding, seropositive
females represented the main source of infection for the
newborns. However, it was not clear whether they were
chronically infectious or in a re-activated infectious sta-
tus due to the immuno-suppressed conditions during
breeding.
Current knowledge on the immunology of B. bronchi-
septica infection is largely derived from laboratory work
with rats and mice and occasionally rabbits [14-21]. Stu-
dies on mice suggest that the bacterium stimulates an
initial strong innate and subsequent acquired immune
response characterized by the clearance of the bacteria
from the lower respiratory tract but the persistence in
the nasal cavity up to 270 days post infection, with the
potential for life-long bacteria shedding [15]. The
mechanisms involved in the persistence of bacteria in
the nasal cavity are still unclear but the adhesin filamen-
tous hemagglutinin (FHA) appears to play an important
role in the colonization of the unciliated olfactory
epithelia [22]. While highly informative, rats and mice
show no documented ability for oro-nasal B. bronchispe-
tica transmission and are not useful hosts for exploring
the effect of host immunity on bacteria shedding and
transmission in general [23,24].
Motivated by our recent work on the epidemiology of
B. brochiseptica infection in a natural system, we exam-
ined whether chronically infected individuals can be
long-term, constant bacteria shedders or whether the
frequency and intensity of shedding changes with time
and between individuals as constrained by their immune
response; for example, hosts may not shed bacteria
despite being chronically infected. We established a
laboratory model system wherein rabbits were infected
with B. bronchiseptica strain RB50 and acquired immu-
nity and bacteria shedding was quantified for 150 days
post infection. We focused our attention on the
immunological parameters relevant to the dynamics of
B. bronchiseptica, as previously identified in mice and
rabbits, and examined how they affect the intensity and
duration of the oro-nasal shedding.
Results
To highlight heterogeneities in the shedding pattern and
associated immune response between individuals, blood
and tissue samples were individually processed.
Infection of rabbits with B. bronchiseptica RB50
Intranasal infection of rabbits led to the successful coloni-
zation and establishment of bacteria in the entire respira-
tory tract. By 3 days post infection (DPI) the mean
number of bacteria colonies in the respiratory tract was
232 times higher than the initial inoculum (50,000 CFU/
ml, Fig. 1). Levels peaked at day 7 post infection in all the
three organs but quickly decreased thereafter and, by 150
days post infection, B. bronchiseptica was completely
cleared from the trachea and lungs but persisted in the
nares (Fig. 1). The number of bacteria consistently
declined with the duration of the infection, DPI (coeff ±
S.E.: -0.111 ± 0.013 d.f. = 30, P < 0.0001) but nares
were significantly higher than either trachea or lungs
Figure 1 Mean number of bacteria (CFUs/g ± S.E.) in the
respiratory tract of infected rabbits at days 3, 7, 14, 30, 60, 90,
120 and 150 post-infection (DPI). Initial infection dose is reported
(Day 0 = log(50,000 CFU/ml+1)). At each day post infection, lungs,
trachea and nasal cavity were collected from 4 infected and 2
control rabbits and individually stored in PBS. Serial dilutions of the
homogenates were plated out on BG blood agar plates
supplemented with streptomycin. Bacteria were enumerated after
incubating for 36-48hr at 37°C. The number of bacteria significantly
declined with infection time (LME, DPI: P < 0.0001) and was
significantly higher in the nares than trachea or lungs (LME, Organs:
P < 0.0001).
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Page 2 of 9(coeff ± S.E.: 0.069 ± 0.017 d.f. = 60 P < 0.0001), once
differences among individuals and the non-independent
sampling of the three organs from the same host were
taken into account. Number of bacteria in the respiratory
tract was negatively affected by serum IgG and circulating
lymphocytes (coeff. ± S.E.: -6.5714 ± 1.002 and -0.853 ±
0.306, respectively) but positively influenced by circulating
neutrophils (coeff. ± S.E.: 1.709 ± 0.524), when corrected
by host variability and the non-independence of sampling
the three respiratory organs from the same individual (For
all: d.f. = 23, P < 0.01). The analysis repeated for each
organ confirmed the negative effect of IgG on bacteria in
the nares (coeff ± S.E.: -4.221 ± 0.854, d.f = 30, P < 0.0001)
but also highlighted the positive effect of IL-10 (coeff ±
S.E: -4.210 ± 0.512) and the negative role of IL-4 (coeff ±
S.E: 3.431 ± 0.748) on bacteria in the lungs (analysis based
o nC tv a l u e s ,f o rb o t h :d . f .=2 8 ,P<0 . 0 0 0 1 ) .I ti si m p o r -
tant to note that the cycle threshold (Ct) is inversely
related to cytokine expression level, therefore and as
reported above, the sign of the coefficient describing the
CFU-Ct relationship should be interpreted as positive
when negative and vice-versa. Results also showed a nega-
tive effect of serum antibodies and circulating lymphocytes
(IgG, IgA and lymphocytes coeff ± S.E.: -9.564 ± 1.225,
-5.046 ± 1.769 and -1.006 ± 0.372, respectively) and a posi-
tive effect of circulating neutrophils (coeff ± S.E.: 2.168 ±
0.636) on bacteria in the trachea (for all: d.f.= 22, P <
0.01). Overall, these findings support the hypothesis that
IgG, IgA, neutrophils and lymphocytes are heavily
involved in B. bronchiseptica clearance from the lower but
not the upper respiratory tract, despite the negative effect
of IgG. The positive association with neutrophils is prob-
ably caused by their rapid recruitment and short-lived
contribution in the bacteria removal, as previously
recorded [15,25]. Moreover, our results further support
the suggestion of an immunological interference between
antibody-mediated clearance (mainly by IgG) and antago-
nistic IL-10 anti-inflammatory activity in the lungs, which
may explain the delay in bacteria clearance from this site
as reported in other models [17].
Bacteria shedding
T h eg o a lo ft h i ss t u d yw a st oq u a n t i f yt h er a t eo f
B. bronchiseptica shedding in relation to the immune
response and to use this finding to gain stronger
insights into the epidemiology of a chronic infection.
The strain of B. bronchiseptica used in this work was
originally isolated from the nares of a 3 month old
New Zealand White rabbit and it was assumed that it
could be naturally transmitted between individuals
[14]. Indeed, we found that rabbits were able to shed
bacteria onto a BG blood agar plate by direct oro-nasal
contact, which mimicked the natural contacts observed
between free living individuals. Mean number of
bacteria shed per second was 0.028 (± 0.001 S.E.)
CFUs; shedding was high during the first month post
infection and again 15 weeks later but substantially
dropped between the two peaks (Fig. 2). Based on the
longitudinal data (weekly sampling of individuals for
serum antibodies and blood cells), we found a signifi-
cant negative effect of IgG on number of bacteria shed
(coeff ± S.E: -0.092 ± 0.025 df = 88 P < 0.0001), once
corrected by host variability. Blood cells did not contri-
bute to the pattern observed. The analysis was
repeated using bacteria CFU counts from the nares of
animals sampled at 60, 90, 120 and 150 post infection,
and a weak but significant positive relationship was
observed between bacteria shed at these sampling
points and bacteria in the nasal cavity (coeff ± S.E.:
0.37e-7 ± 0.14e-7 d.f. = 8 P < 0.030). Together these
results suggest that shedding is positively influenced by
the level of infection in the oro-nasal cavity and nega-
tively affected by serum IgG.
Three main patterns of shedding were identified dur-
ing the course of the infection: i- bacteria were shed
Figure 2 Mean number of bacteria shed (CFUs/sec ± S.E.) by
oro-nasal contact with a BG blood agar plate during the
course of the infection. A total of 14 infected rabbits were used
and sacrificed at days 60, 90, 120 and 150 post-infection. Each
individual was weekly challenged by oro-nasal contact with a BG
blood agar plate and time of interaction measured. Bacteria were
enumerated after incubating for 36-48 hr at 37°C. For every week
post infection (from WPI 2 to WPI 18) the number of plates positive
for B. bronchiseptica after removal of contaminated cases and
sacrificed individuals was: WPI 2 = 8, WPI 3 = 6, WPI 4 = 8, WPI 5 =
N.D. (no data), WPI 6 = 11, WPI 7 = N.D., WPI 8 = 14, WPI 9 = 12,
WPI 10 = 12, WPI 11 = 12, WPI 12 = 12, WPI 13 = 8, WPI 14 = 8,
WPI 15 = 8, WPI 16 = 8, WPI 17 = 8, WPI 18 = 4. The overall
average shedding pattern and the more specific three shedding
groups (intermittent, fade-out and non-shedding) are reported.
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tent’ group, 46% of individuals), ii- intensity of bacteria
shed fell with the progression of the infection (‘fade-out’
group, 31%) and iii- individuals never shed bacteria
despite being infected (‘non-shedders’, 23%) (Fig. 2). To
highlight immunological differences associated with
these shedding patterns, analyses were repeated among
the three groups using longitudinal blood data. No sig-
nificant differences in serum IgG, IgA, neutrophils and
lymphocytes were observed among the three patterns,
however, the intercept of the models was consistently
significant (for all: P < 0.05), once corrected for variabil-
ity between hosts and their multiple sampling. This
finding supports the hypothesis that the strength of the
initial immune response is crucial in modulating the
dynamics of shedding. During the second week post
infection, differences in the dynamics of infection were
observed between the intermittent and the fade-out
group (no data were available for the non-shedding
group). The relatively low number of bacteria shed by
the intermittent group (mean CFU/sec. ± S.E.: 0.083 ±
0.019) was associated with low serum IgG (OD index ±
S.E.: 0.238 ± 0.028) and high serum IgA (1.107 ± 0.052)
as well as high circulating neutrophils (mean K/μL±
S.E.: 1.436 ± 0.158) and lymphocytes (mean K/μL ± S.E.:
2.150 ± 0.412). In contrast, the higher shedding in the
fade out group (mean CFU/sec. ± S.E.: 0.213 ± 0.045)
was correlated to high serum IgG (OD index ± S.E.:
0.434 ± 0.118) and low serum IgA (0.667 ± 0.128) and
white blood cells (mean K/μL±S . E . ,n e u t r o p h i l s :
0.896 ± 0.00 and lymphocytes: 0.740 ± 0.000). Although
not conclusive or statistically significant, these relation-
ships suggest that the strength of the early antibody and
blood cells response may play a role in affecting both
the initial and long-term pattern of B. bronchiseptica
transmission.
Host immune response overview
Overall, the immune response of rabbits to B. bronchi-
septica infection confirmed previous findings reported in
other animal models [14-19,25].
Peripheral response
Infected hosts developed a strong serum IgG and IgA
response compared to the controls (Fig. 3). The level of
IgG rapidly increased in infected rabbits and remained
consistently high for the duration of the infection, how-
ever and as previously highlighted, it was not sufficient
to completely clear the bacteria from the upper respira-
tory tract (interaction between sampling time and
infected-controls, coeff ± S.E.: 0.047 ± 0.005 d.f. = 328 P
< 0.0001 -corrected for the random effect of the host
and its longitudinal sampling). IgA levels in infected
rabbits peaked around week three post infection and
decreased thereafter, probably as a consequence of the
successful clearance of bacteria from the lower respira-
tory tract [25,26]. Nevertheless, values remained signifi-
cantly higher in infected compared to controls (coeff ±
S.E.: 0.208 ± 0.056 d.f. = 45 P < 0.001) and for the dura-
tion of the experiment (interaction between infected-
controls and sampling time, coeff ± S.E.: 0.0026 ± 0.001
d.f. = 410 P < 0.01; corrected for the host variability).
Collectively, the systemic antibody profiles suggest that
rabbit immune protection against B. bronchiseptica is
robust for the first 5 months (150 days) post infection
but does not result in complete clearance.
The neutrophil concentration in the blood decreased
with the duration of the infection (coeff ± S.E.:-0.011 ±
0.002 d.f = 334 P < 0.0001) and was similar between
Figure 3 Mean serum antibody response (OD index ± S.E.) in
infected and control rabbits by sampling week (WPI). Serum was
collected twice from all individuals prior to infection (48 rabbits
sampled at week -1) and weekly thereafter. Number of samples
decreased with time of infection as groups of 6 individuals (4 infected
and 2 controls) were regularly sacrificed. Sera were assayed
individually.
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tion, where a significant neutrophilia was observed in
infected compared to controls (coeff ± S.E.: 0.159 ± 0.075
d.f. = 27 P < 0.05). These findings further support the
short-lived and early involvement of neutrophils in
B. bronchiseptica clearance [15,27].
Cytokine response in the lungs
As shown in fig. 4 and based on the 2
-ΔΔct transforma-
tion, a high IL-10 expression was observed in the lungs
of infected rabbits in the first 30 days post infection, this
was followed by a short-lived peak in IFN-g at 60 days
post infection, and a general decrease in cytokine expres-
sion thereafter. IL-4 showed consistent baseline expres-
sion. Overall and using the raw Ct values for analysis
tractability, results confirmed the important anti-inflam-
matory role of IL-10 in B. bronchiseptica infected rabbits
(interaction between infected-controls and sampling
time, coeff ± S.E.: 0.001 ± 0.0001 d.f. = 41 P < 0.05, cor-
rected for the random effect of the host). IFN-g and IL-4
Ct values significantly changed among sampling time but
not between infected and controls (respectively, coeff ±
S.E.: 0.001 ± 0.0003 and -0.001 ± 0.0003 for both d.f. =
42 P < 0.05). Through its anti-inflammatory properties
and involvement in the recruitment and activation of
other anti-inflammatory cells [28,29], IL-10 probably
facilitated the establishment of bacteria in the respiratory
tract and the subsequent persistence in the nares, while
the peaks at 7 and 60 days post infection in IFN-g
confirmed its important role in bacteria clearance from
the lungs and possibly trachea. In summary, the
dynamics of cytokine expression in the lungs of infected
rabbits was in line with previous studies [20,21].
Discussion
This study showed that rabbits infected with Bordetella
bronchiseptica strain RB50 were able to shed bacteria
by oro-nasal contact for at least 128 days post infec-
tion. Individuals naturally interacted with BG blood
agar plates and a few minutes of direct contact were
sufficient for the transmission of bacteria onto the
medium. The mean number of bacteria shed followed
the dynamics of infection, in that, shedding was high
during the initial first month and decreased thereafter,
although occasional peaks were observed up to
17 weeks post infection. The variability in the shedding
pattern was unexpected but supports the hypothesis
that rabbits with a chronic B. bronchiseptica infection
can be long-term shedders, through a persistent infec-
tion in the upper respiratory tract. Specifically, most of
the bacteria were shed at irregular intervals and with
intensities that vary both within and between indivi-
duals. However, we also showed that some individuals
never shed bacteria while infected, and this supports
the hypothesis of a non-linear relationship between
host infectiousness and B. bronchiseptica transmission.
Moreover, since the immune system imposed con-
strains on the level and duration of infection we may
argue that there was also a non-linear relationship
between immune response and transmission dynamics.
The host acquired immunity, and probably the level
of the early response, influenced the intensity, duration
and pattern of bacteria shed. Serum IgG appeared to
contribute to bacteria clearance in the lungs and tra-
chea and the initial reduction in the nares. IgG also
exerted a negative effect on the amount of B. bronchi-
septica shed and together with IgA and white blood
cells appeared to influence the initial and long-term
shedding pattern. Indeed, a robust and timely IgG
response probably modulated the long term shedding
of B. bronchiseptica by quickly reducing or controlling
replication in the nares below a threshold value
required for consistent and prolonged pathogen trans-
mission. In contrast, it is possible that the initial lower
infection levels stimulated a milder immune response
that allowed bacteria replication above a threshold
necessary for long term shedding. While the number
of bacteria in the nares was positively associated to the
level of bacteria shed, some infected individuals never
shed bacteria, supporting the hypothesis that a mini-
mum threshold level of infection is necessary for
bacteria shedding.
Figure 4 Cytokine gene expression profiles in the lungs at
days 3, 7, 14, 30, 60, 90, 120 and 150 post-infection (DPI).
Cytokine data are presented using the 2
-ΔΔCt ± S.E approach. Briefly,
for each rabbit cytokine expression was scaled relative to the
housekeeping gene HPRT (Ct), Ct values from infected individuals
were then scaled over the controls.
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clearance of the lower respiratory tract, which agrees
with the general role of this immunoglobulin in the
early protection against invasive infections [26]. Serum
IgG and IgA have been previously shown to be sufficient
for B. bronchiseptica clearance in the lower but not the
upper respiratory tract [16-18,25]. Similarly, neutrophils
are involved in the early clearance of B. bronchiseptica
from the lower respiratory tract [16,26,30]. Our findings
on the role of serum antibodies and bacteria clearance
are in line with previous work but also highlight the
effect of serum IgG on the dynamics of B. bronchisep-
tica shedding.
At the cytokine level, the high IL-10 in the lungs dur-
ing the initial 2 months of infection, was fundamental to
delay clearance in the lower respiratory tract and prob-
ably contributed to the persistence of bacteria in the
nasal cavity and associated shedding. Indeed, the
absence of IL-10 synthesis has been related to augmen-
ted B. bronchiseptica clearance as well as reduced, albeit
more effective, antibody production and higher IFN-g in
mice [17]. The association between serum antibodies,
cytokines and bacteria shed has been reported in other
host-bacteria systems. For example, a negative relation-
ship between fecal shedding of Escherichia coli O157:H7
and IgG and IgA was observed in cows previously
infected with a homologous bacteria strain [31]. Muco-
sal IgA was shown to reduce vaginal shedding and re-
infection with C. trachomatis in mice [32], while human
infections with Campylobacter spp. exhibited an inverse
relationship between the shedding of fecal bacteria and
age-dependent increases in serum IgG and IgA [33].
Moreover, IFN-g expression appeared to contribute to
the reduction of Chlamydia trachomatis and C. muri-
darum shedding in mice [34,35].
Conclusions
We showed that rabbits were heterogeneous in their
pattern of shedding B. bronchiseptica a n dt h a tt h i sw a s
associated with differences in the host immune
response. The dynamics of infection and partial clear-
ance was consistent among individuals and a positive
relationship was observed between bacteria shed and
bacteria in the nasal cavity. Yet, some hosts shed bac-
teria intermittently, others shed bacteria only during the
initial few weeks of infection while some individuals
never shed bacteria. Together these findings suggest a
strong non-linear relationship between force of infec-
tion, immune response and shedding rate for this
chronic infection. The molecular mechanisms regulating
these interactions are still obscure and more studies are
needed to understand the persistence of bacteria in the
upper respiratory tract as well as the processes
controlling bacteria dispersal through direct oro-nasal
contact or aerosol.
The occurrence of individuals that did not shed bac-
teria and the exclusion of a few contaminated plates,
especially from the early part of the study, affected our
search for a robust association between shedding pat-
terns and the immune response. Nevertheless, the gen-
eral patterns of bacteria dynamics and immune
response, currently described, are consistent in this
host-pathogen system as confirmed by our more recent
studies on rabbits co-infected with B. bronchiseptica and
gastrointestinal nematodes (unpubl. data). In conclusion,
more attention should be given to the understanding of
the relationship between host immune response, the
level of infection and heterogeneities in pathogen
shedding.
Methods
Bacteria strain and culture
The Bordetella bronchiseptica strain RB50 used in this
study was kindly provided by Dr. E. T. Harvill (Penn
State University, PA, USA). Bacteria were grown on Bor-
det-Gengou (BG) agar (HiMedia, USA) supplemented
with 10% defibrinated sheep blood (Hema Resources,
USA) and streptomycin (20 μg/ml, Sigma-Aldrich Co.,
USA). The bacteria inoculum was prepared by growing
in Stainer-Scholte (SS) liquid culture medium at 37°C
overnight on a rotary shaker to an optical density at 600
nm of approximately 0.3. For the infection, bacteria
were re-suspended in sterile phosphate-buffered saline
( P B S )a tad e n s i t yo f5×1 0
4 CFUs/ml, which was con-
firmed by plating serial dilutions of the inoculum on BG
blood agar plates in triplicate.
Study design
Out-bred, 60 days old New Zealand White male rabbits
free from B. bronchiseptica and other pathogens/para-
sites (Harlan, USA), were housed in individual cages
with food and water ad libitum and a 12 h day/night
cycle. Individuals were lightly sedated intravenously with
a pre-mixed solution of Ketamine (5 mg/kg, Phoenix
Pharmaceuticals, USA) and Valium (0.25 mg/kg, Hos-
pira, USA) and intra-nasally infected by pipetting in
each nare 0.5 ml of PBS containing 2.5 × 10
4 B. bronchi-
septica (dose adapted from [14]). Control animals were
sham inoculated with 1 ml of sterile PBS. Groups of
6 individuals (4 infected and 2 controls) were euthanized
with 1 ml of pentobarbital (Euthasol, Virbac) at days 3,
7, 14, 30, 60, 90, 120 and 150 post-infection (DPI) and
the lungs, trachea and nasal cavity removed aseptically.
Blood samples were collected weekly from the marginal
ear vein of all animals. Animals were weighed weekly
and monitored routinely for health status. All listed
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tional Animal Care and Use Committee of The Pennsyl-
vania State University.
Quantification of bacteria in the respiratory tract
Following euthanasia, a weighed amount of the trachea
and nasal cavity (turbinates and septum) were homo-
genized in 5 and 15 mls of PBS, respectively. The lungs
were blended and approximately 3 g of the mix trans-
ferred into tubes containing RNAlater (Qiagen) and
stored at -80°C for subsequent cytokine determination.
The remaining tissue was homogenized in 15 ml of ster-
ile PBS. Serial dilutions of the tissue homogenates were
plated onto BG blood agar plates and incubated at 37°C
for 48 hours to allow bacteria quantification.
Quantification of bacteria shed
To monitor the weekly amount of bacteria shed,
14 infected rabbits were selected from the late sampling
points (60, 90, 120 and 150 DPI). Every week, a BG
blood agar plate was left in each cage for a maximum of
10 minutes and rabbits were allowed to interact with
the plate by direct oral-nasal contact; the duration of
each interaction was recorded. Plates were removed in
case individuals chewed the plastic or ate the agar.
Bacteria colonies were counted after incubation at 37°C
for 48 hours; data were expressed as number of bacteria
colonies shed per second of active interaction. This pro-
cedure is analogous to a natural transmission process
compared to the nasal swabbing method that is more
invasive, disruptive of the bacteria population and less
representative of the individual’s ability to shed bacteria
[36-38]. We were not able to record the first week post
infection data due to technical problems.
Enzyme-Linked Immunosorbent Assay (ELISA)
Serum was collected once a week from all animals and
separated from the red blood cells by centrifugation
(10,000 rpm for 10 min) and stored at -80°C. Antigen
coated plates were prepared by growing B. bronchisep-
tica overnight to mid-log phase in SS culture medium
(OD at 600 nm of 0.6), washed once and re-suspended
in PBS. Bacteria were heat inactivated at 65°C for
30 minutes, centrifuged at 5000 rpm for 15 minutes at
4°C and the resulting lysate estimated for protein con-
centration with the BCA assay (Pierce Biotechnology).
The lysate was diluted in 0.2 M carbonate/bicarbonate
coating buffer (pH 9.6) to obtain a final concentration
of 6.5 μg/ml. 100 μl was used to coat the wells of 96-
well polystyrene plates (Greiner Bio-One). Plates were
incubated overnight at 4°C and then frozen at -20°C
until use. Prior to serum addition, the plates were
thawed at 37°C for 1 hour and blocked in 5% non-fat
milk and PBS-T for 1 hour. The optimal serum dilution
for the IgA and IgG ELISA assays was performed fol-
lowing Sanchez et al. [39] and Crowther [40]. A pool
from strongly reacting serum samples (high pool pre-
pared from infected individuals 4-6 weeks post-infec-
tion) and a pool from non-reacting serum samples (low
pool from all individuals prior to infection) were pre-
pared and a checkerboard titration was performed by
serial dilutions of the strongly reacting serum pool
against dilutions of the detection antibody, anti-rabbit
IgA (Abcam, USA) or anti-rabbit IgG (Southern Bio-
technology, USA). Optimal dilutions for the serum and
detector antibody were selected by visually identifying
the inflection point from the resulting dilution curves;
the dilutions established for the serum were 1:10 for
IgA and 1:10,000 for IgG, while for anti-rabbit IgA it
was determined to be 1:5,000 and for anti-rabbit IgG,
1:10,000. Each sample from each individual was per-
formed in duplicate with all plates having the high, low
and background controls. Serum samples from each rab-
bit at every sampling point were added to the wells in
blocking buffer at the appropriate final dilutions, and
incubated at 37°C for 2 hours in a humidified chamber.
Plates were then washed 4 times with PBS-T between
each incubation and developed with 2,2’-Azino-bis(3-
ethylbenzthiazoline-6-sulfonic acid) (Sigma-Aldrich) for
30 minutes and read with a spectrophotometer at 405
nm. Values were expressed as immunosorbent optical
densities (OD).
To confirm the consistency of the ELISA results among
plates, the relationship between corrected high antibody
controls (high control - background control) and cor-
rected low antibody controls (low control - background
control) was examined; plates were repeated if the ratio
was not consistent with a linear relationship among all
plates showing a Pearson’s correlation coefficient above r
= 0.70. Background corrected antibody values were then
transformed and standardized into optical density (OD)
indexes as: Xi = (OD test sample-OD negative control)/
(OD positive control-OD negative control) where Xi
represents a replicate for each individual at every sam-
pling point; the average of the two replicates (Xi = mean
(X1+X2)) was then estimated for each individual at each
sampling point [39]. To remove the occasional negative
values, data were corrected as: Xi* = Xi+|min(total Xi)|.
The new standardized mean optical density indexes were
used in the statistical analyses.
Haematology
A small aliquot (0.2 ml) of blood collected weekly from
every animal was stored in EDTA coated tubes (Sartor-
ius, Germany) and the most common cellular com-
ponents in the blood (neutrophils, lymphocytes,
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were quantified using the Hemavet 3 hematology system
(Drew Scientific, USA).
Quantification of cytokines gene expression in the lung
Cytokine gene expression in the lung was determined
using a real-time quantitative PCR approach. For RNA
extraction and purification, tissues were homogenized
with a rotor-stator (Polytron PT 2100, Kinematica) in
TRIzol reagent (Invitrogen). RNA was digested with 4 U
TURBO DNA-free DNase (Ambion) and residual DNA
contamination was assessed by performing quantitative
PCRs. 1 μg of RNA was reverse transcribed with the
High Capacity RNA-to-cDNA kit (Applied Biosystems).
The resultant complementary DNA product (cDNA)
was used to detect expression of IFN-g, IL-4 and IL-10,
with Hypoxanthine Phosphoribosyl Transferase (HPRT)
as the housekeeping gene [41], using commercially avail-
able or custom made primers and probes (Applied Bio-
systems). The primer and probe sequences were based
on a plasmid kindly provided by Dr. Sheila Lukehart
(University of Washington, WA) [41]. The plasmid was
also used to verify amplification efficiencies of the pri-
mer probe pairs (450 μM primers and 125 μM probe)
by performing quantitative PCRs with 10-fold serial
dilutions of the plasmid. The Pearson correlation coeffi-
cients between each cytokine and the housekeeping
gene were always high (for all: r > 0.99). The sequences
of the primer-probe pairs were as follows: HPRT (for-
ward primer; 5′-CTCTCAACCTTAACTGGAAA-
GAATGTCT-3′, reverse primer; 5′- GGAAAGCAA
GGTCTGCATTGTT-3′, probe 5′-6FAM-TTGCCAGTG
TCAATTAT-NFQ-3′), IFN-g (forward primer; 5′-
GCTTTTCAGCTCTGCCTCATCTT-3′, reverse primer;
5′- GGTTAGTGTGTCCTGGCAGTAA-3′,p r o b e5 ′-
6FAM-CAGCCGTAAGAACCC-NFQ-3′), IL-10 (Taq-
man assay ID; Oc03396942_m1, Applied Biosystems)
and IL-4 (forward primer; 5′-ATGCACCAAGCTGAT-
GATAGCA-3′, reverse primer; 5′-CCTCTCTCTC
GGTTGTGTTCTT-3′, probe 5′-6FAM-CCCTGGCCGT
CCCC-NFQ-3′). Quantitative PCRs were performed on
an ABI7500 real time thermal cycler set in ‘fast’ mode
for 40 cycles and using the PerfeCTa™ qPCR enzyme
FastMix, UNG, Low ROX (Quanta Biosciences).
For visual purposes, changes in cytokines expression
in the lungs were initially corrected for the house keep-
ing gene (Ct values) and then scaled using the relative
transcript level in fold change between infected at every
sampling point (DPI) and the average of the controls
from the whole experiment, following the comparative
2
-ΔΔCt method [42]. For analytical purposes, the
corrected Ct values were used.
Data analysis
Data were analyzed using linear mixed effect models
(LME-REML) unless otherwise stated. To explore how
bacteria shedding was affected by the host immune
response, the number of colonies shed per interaction
time was examined in relation to bacteria CFU count,
antibody levels, blood cell values and infection time
(week post infection WPI or days post infection DPI
depending whether we used longitudinal or point based
data). Individual identification code (ID) was considered
as a random effect and the non-independent sampling
of the same individual through time was quantified by
including an autoregressive function of order 1 (AR1)
on the individual ID. Changes in bacteria colonies estab-
lished in the respiratory tract were examined in relation
to the three respiratory organs and infection time (DPI),
where individual ID was considered as a random effect
and an autoregressive function of order 1 (AR1) was
applied to the individual ID to take into account the
non-independent response of the three correlated organs
within each individual. This analysis was repeated for
each organ and by including cytokines expression for
the lungs. Linear mixed effect models were also per-
formed to highlight differences between treatments
(infected and control) and sampling time (WPI or DPI)
in serum antibody response (IgA and IgG), white blood
cells concentration and cytokine expression; again the
individual ID was treated as a random or correlated
effect (AR1) when necessary.
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